2019 Cannabis Business Award's Publication of the Year |
FLORIDA SUPREME COURT SAYS YES!! |
FMCPG HAS BEEN SERVING AND REPRESENTING THE CANNABIS PHYSICIAN COMMUNITY SINCE 2020 |
THE
"FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP"
(FMCPG) FOR ALL
"MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY " DISCUSSION WILL INCLUDED:
RESULTS OF SURVEY
REVIEW OF THE OMMU AND CHANGES TO THE DOCTOR'S PATIENT INPUT PORTAL ON THE OMMU WEBSITE.
DOCTORS WITHIN OUR GROUP WILL DISCUSS HOW THEY HAVE BEEN WORKING AROUND SOME OF THE CHANGES
HEMP BILL - WHAT DOES IT MEAN FOR MEDICAL CANNABIS
LEGISLATIVE AGENDA FOR 2024 -2025
REF'S ISSUES AND SOLUTIONS
CLICK HERE TO REGISTER FOR THE JULY 10, 2024 MEETING |
MEDICAL CANNABIS PHYSICIAN PROMOTION PACKAGE BY
CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks). E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast. The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S
IN FLORIDA Click on Company Logo to be Transferred to Web Site
|
Top Ten States Attracting Investors |
Top Ten States Attracting Buyers |
View This Week's Regional Deal Tracker to See Our Detailed Analysis of Cap Raises and M&A by State About The Viridian Cannabis Deal Tracker
Launched in January 2015, and having analyzed more than $75B in deals, the Viridian Cannabis Deal Tracker is a proprietary data service that monitors and analyzes capital raise and M&A activity in the legal Cannabis, Hemp, and Psychedelics industries. Our insights help companies, investors, lenders and acquirers make informed capital allocation decisions. Each week the Deal Tracker provides proprietary data and market intelligence on transactions, including:
- Deals by Industry Sector (Track the Flow of Capital and M&A Deals by Industry Sector)
- Deal Structure (Equity/Debt for Capital Raises, Cash/Stock/Earnout for M&A)
- Principals to the Transaction (Issuer/Investor/Lender/Acquirer)
- Key Deal Terms (Deal Size, Valuation, Pricing, Warrants, Cost of Capital)
- Deals by Location of Issuer/Buyer/Seller (Track the Flow of Deals by State and Country)
- Credit Ratings (Leverage and Liquidity Ratios)
Contact
Scott Greiper
CEO
Viridian Capital Advisors, LLC
646.330.0704
sgreiper@viridianca.com |
NATIONAL AND INTERNATIONAL NEWS |
GLOBAL MEDICAL CANNABIS MARKET SIZE TO REACH USD 77.13 BILLION BY 2032, DRIVEN BY AN 18.24% CAGR | STRAITS RESEARCH
MEDICAL CANNABIS MARKET SIZE, SHARE & TRENDS ANALYSIS REPORT BY PRODUCT TYPE (SOLIDS, DISSOLVABLE/POWDERS, OIL, OINTMENTS AND CREAMS), BY DERIVATIVE (CANNABIDIOL, TETRAHYDROCANNABINOL), BY ROUTE OF ADMINISTRATIVE (INHALATION, ORAL, TOPICAL), BY APPLICATIONS (PAIN MANAGEMENT, NEUROLOGICAL HEALTH MANAGEMENT, MENTAL HEALTH MANAGEMENT), BY DISTRIBUTION CHANNEL (HOSPITAL PHARMACY, RETAIL PHARMACY, ONLINE PHARMACY) AND BY REGION(NORTH AMERICA, EUROPE, APAC, MIDDLE EAST AND AFRICA, LATAM) FORECASTS, 2024-2032
New York, United States, July 04, 2024 — As per the latest report by Straits Research, the global medical cannabis market size was valued at USD 17,075.39 million in 2023. It is expected to reach USD 77,134.83 million by 2032, growing at a CAGR of 18.24% during the forecast period (2024–2032).
Medical marijuana, also called medical cannabis, is a herbal medication derived from Cannabis plants used to treat a specific symptom or illness, such as cancer, persistent pain, or mental disorders. The two main cannabinoids extracted from this plant and used medicinally are tetrahydrocannabinol (THC) and cannabidiol (CBD). Increased consumer awareness of the health benefits of cannabis and its expanding medical applications, such as the treatment of cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, an acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), Alzheimer’s, post-traumatic stress disorder (PTSD), and Parkinson’s disease drive the growth of the medical cannabis market. In addition, the market expansion is fueled by novel product development and increased R&D efforts.
READ MORE |
TREEZ EXPANDS INTO NEW YORK MARKET, BRINGING SOLUTIONS THAT ELEVATE THE CANNABIS RETAIL EXPERIENCE
NEW YORK, July 9, 2024 — Treez, the leading provider of technology solutions that enable profitability for cannabis retailers, proudly announces its expansion into the New York market. This strategic move marks a significant milestone in Treez’s mission to empower operators to uplevel their retail operations and customer experience.
As the industry’s retail landscape continues to evolve, Treez is committed to helping retailers grow revenue, reduce operating costs, and accelerate profitability. By entering New York, Treez aims to equip dispensaries across the state with the tools necessary to thrive in an increasingly competitive market environment.
“New York operators deserve a technology partner dedicated to elevating their retail experience,” emphasized Suresh Khanna, President and COO of Treez. “As the highest volume operators in many other states already know, Treez prides itself on unrivaled uptime and fanatical customer support, ensuring our retail partners have the foundation to deliver exemplary customer experiences every time. Expanding to serve New York underscores our commitment to empowering the industry’s most ambitious retailers with superior technology and service. Our top team is already on the ground preparing for our first customer launches.”
READ MORE |
SPRINGBIG ANNOUNCES STRATEGIC PARTNERSHIP WITH NATIVE ROOTS, EXPANDING CANNABIS LOYALTY MARKETING REACH
DENVER, July 09, 2024 — Springbig, the leader in cannabis loyalty marketing and communications technology, is excited to announce our recent signing with Native Roots, Colorado’s largest independently held vertically integrated cannabis company. This partnership marks a significant milestone in our mission to enhance customer engagement and loyalty in the cannabis industry.
Native Roots, renowned for their commitment to quality and customer satisfaction, has chosen Springbig to elevate their customer experience and streamline their marketing efforts. With this collaboration, Springbig will provide Native Roots with advanced technological solutions to improve communication and engagement with their customers, ensuring an unmatched customer experience.
“At Native Roots, we were on a quest for a solution that valued the functionality of their platform from the business side while prioritizing the customer experience. We sought a partner that was committed to solving the business problems that we face with tested and effective solutions. Finally, we required a partner that would integrate seamlessly into our team. We found these qualities in Springbig beginning in our initial conversation and we’re impressed to find these synergies continuing to be delivered,” said Buck Dutton, VP of Marketing at Native Roots.
READ MORE |
TILRAY MEDICAL ANNOUNCES SCIENTIFIC STUDY ON MEDICAL CANNABIS FOR PATIENTS OVER AGE 50
OLDER PATIENTS REPRESENT A RAPIDLY GROWING SUBSET FOR THERAPEUTIC MEDICAL CANNABIS USE FOR PAIN, SLEEP, QUALITY OF LIFE AND CO-MEDICATION
BERLIN, July 09, 2024 — Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a new Tilray-led scientific publication titled, Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes. The Medical Cannabis in Older Patients Study (“MCOPS”) is a multi-site, prospective, observational study examining the real-world impact of medical use on patients over the age of 50 and under the guidance of a healthcare provider.
The MCOPS study comprised of 299 participants with an average age of 66.7 years and 62.2% of respondents identified as female. Approximately 90% of patients used medical cannabis to treat pain-related conditions such as chronic pain and arthritis. This study presents to the medical and scientific community the impact of medical cannabis on health outcomes, with a focus on pain, sleep and quality of life.
Under medical cannabis guidance and care, the MCOPs shows correlation with improvements in pain scores, sleep and quality of life in a still growing subset of patients. A significant reduction of co-medication was observed, indicating that the treatment with medical cannabis can be a cost-effective option for this population.
READ MORE | AFC GAMMA RECONFIRMS COMPLETION DATE OF SPIN-OFF OF COMMERCIAL REAL ESTATE PORTFOLIO
Record Date for Distribution of Sunrise Realty Trust to be July 8, 2024
Distribution Date to be July 9, 2024
WEST PALM BEACH, Fla., July 08, 2024 — AFC Gamma, Inc. (NASDAQ:AFCG) (“AFC Gamma”) today reconfirms that the spin-off of its commercial real estate portfolio into an independent, publicly-traded REIT, Sunrise Realty Trust, Inc. (“SUNS”), will be completed on July 9, 2024.
Shareholders of AFC Gamma common stock as of the close of business on July 8, 2024 (the “Record Date”) will receive one share of new SUNS common stock for every three shares of AFC Gamma common stock held on the Record Date. The distribution is expected to occur before trading begins on July 9, 2024 (the “Distribution Date”), and SUNS common stock will trade on the Nasdaq Capital Market under the symbol “SUNS”. AFC Gamma will not issue fractional shares of its common stock in the distribution. Instead, holders of AFC Gamma common stock will receive cash in lieu of any fractional shares that they would otherwise be entitled to. No action is required from AFC Gamma stockholders to receive the distributed SUNS common shares.
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS
OVER 881,000
AND 655 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
JULY 5, 2024 Report BY THE NUMBERS
Qualified Patients: (Active ID Card):
JUL 05 2024 881,780
JUN 28 2024- 883,567
JUN 21 2024- 883,375
JUN 14 2024- 882,933
JUN 07 2024- 883,096
Pattients Last Week: -1,787
Qualified Ordering Physicians: 2,271
New Doctors Last Week: 3 Reporting Period: JUNE 28 TO JULY 4, 2024
Amount of Medical Marijuana Dispensed - (mgs THC) 375,215,659
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,877,002
Amount of Marijuana in a From for Smoking (oz) 124,357.726
Approved Dispensing Locations: 655
ADD LAST WEEK : 2
AYR - PANAMA CITY TRULIEVE - GULF BREEZE |
UPCOMING MEETING AND CONFERENCES |
2024 Florida Cannabis Festival November 2nd and 3rd |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|